Systemic absorption of ocularly administered enkephalinamide and inulin in the albino rabbit

Extent, pathways, and vehicle effects

Robert Stratford Jr., L. Wulf Carson, Satish Dodda‐Kashi, Vincent H.L. Lee

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The systemic absorption of ocularly applied tritiated [D‐Ala2]metenkephalinamide (YAGFM) and inulin was studied in the albino rabbit with respect to rate, extent, pathways, and vehicle effects and compared with epinephrine. Peak concentration was achieved within 20 min except for inulin, for which absorption was still ongoing at 120 min. For YAGFM, the apparent absorption rate was slower than the elimination rate, thus obeying “flip‐flop” pharmacokinetics. Based on the area under the plasma concentration curve from zero to 120 min, the percent of dose systemically absorbed was 36.1 ± 4.4% for YAGFM, at least 3.3 ± 0.2% for inulin, and 58.5 ± 4.4% for epinephrine. This suggests that loss of drug to the systemic circulation is a more important factor in reducing the ocular absorption of YAGFM than for inulin. The conjunctival mucosa played as important a role as the nasal mucosa in the systemic absorption of YAGFM, while playing a secondary role in the case of inulin. Unlike nonpeptide drugs, the systemic absorption of ocularly administered YAGFM and inulin was not adversely affected by incorporation in 5% polyvinyl alcohol. Overall, the contact time of the instilled dose with the conjunctival and the nasal mucosae, their intrinsic permeability, and the extent of dilution of the instilled dose are key factors determining the vehicle effects on the extent of systemic absorption of ocularly applied peptides.

Original languageEnglish (US)
Pages (from-to)838-842
Number of pages5
JournalJournal of Pharmaceutical Sciences
Volume77
Issue number10
DOIs
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Inulin
Rabbits
Nasal Mucosa
Epinephrine
Polyvinyl Alcohol
Pharmaceutical Preparations
Physiological Absorption
Permeability
Mucous Membrane
Pharmacokinetics
Peptides

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Systemic absorption of ocularly administered enkephalinamide and inulin in the albino rabbit : Extent, pathways, and vehicle effects. / Stratford Jr., Robert; Carson, L. Wulf; Dodda‐Kashi, Satish; Lee, Vincent H.L.

In: Journal of Pharmaceutical Sciences, Vol. 77, No. 10, 01.01.1988, p. 838-842.

Research output: Contribution to journalArticle

@article{ba2ec9049d3d42e2b08397fd7a69151d,
title = "Systemic absorption of ocularly administered enkephalinamide and inulin in the albino rabbit: Extent, pathways, and vehicle effects",
abstract = "The systemic absorption of ocularly applied tritiated [D‐Ala2]metenkephalinamide (YAGFM) and inulin was studied in the albino rabbit with respect to rate, extent, pathways, and vehicle effects and compared with epinephrine. Peak concentration was achieved within 20 min except for inulin, for which absorption was still ongoing at 120 min. For YAGFM, the apparent absorption rate was slower than the elimination rate, thus obeying “flip‐flop” pharmacokinetics. Based on the area under the plasma concentration curve from zero to 120 min, the percent of dose systemically absorbed was 36.1 ± 4.4{\%} for YAGFM, at least 3.3 ± 0.2{\%} for inulin, and 58.5 ± 4.4{\%} for epinephrine. This suggests that loss of drug to the systemic circulation is a more important factor in reducing the ocular absorption of YAGFM than for inulin. The conjunctival mucosa played as important a role as the nasal mucosa in the systemic absorption of YAGFM, while playing a secondary role in the case of inulin. Unlike nonpeptide drugs, the systemic absorption of ocularly administered YAGFM and inulin was not adversely affected by incorporation in 5{\%} polyvinyl alcohol. Overall, the contact time of the instilled dose with the conjunctival and the nasal mucosae, their intrinsic permeability, and the extent of dilution of the instilled dose are key factors determining the vehicle effects on the extent of systemic absorption of ocularly applied peptides.",
author = "{Stratford Jr.}, Robert and Carson, {L. Wulf} and Satish Dodda‐Kashi and Lee, {Vincent H.L.}",
year = "1988",
month = "1",
day = "1",
doi = "10.1002/jps.2600771005",
language = "English (US)",
volume = "77",
pages = "838--842",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Systemic absorption of ocularly administered enkephalinamide and inulin in the albino rabbit

T2 - Extent, pathways, and vehicle effects

AU - Stratford Jr., Robert

AU - Carson, L. Wulf

AU - Dodda‐Kashi, Satish

AU - Lee, Vincent H.L.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - The systemic absorption of ocularly applied tritiated [D‐Ala2]metenkephalinamide (YAGFM) and inulin was studied in the albino rabbit with respect to rate, extent, pathways, and vehicle effects and compared with epinephrine. Peak concentration was achieved within 20 min except for inulin, for which absorption was still ongoing at 120 min. For YAGFM, the apparent absorption rate was slower than the elimination rate, thus obeying “flip‐flop” pharmacokinetics. Based on the area under the plasma concentration curve from zero to 120 min, the percent of dose systemically absorbed was 36.1 ± 4.4% for YAGFM, at least 3.3 ± 0.2% for inulin, and 58.5 ± 4.4% for epinephrine. This suggests that loss of drug to the systemic circulation is a more important factor in reducing the ocular absorption of YAGFM than for inulin. The conjunctival mucosa played as important a role as the nasal mucosa in the systemic absorption of YAGFM, while playing a secondary role in the case of inulin. Unlike nonpeptide drugs, the systemic absorption of ocularly administered YAGFM and inulin was not adversely affected by incorporation in 5% polyvinyl alcohol. Overall, the contact time of the instilled dose with the conjunctival and the nasal mucosae, their intrinsic permeability, and the extent of dilution of the instilled dose are key factors determining the vehicle effects on the extent of systemic absorption of ocularly applied peptides.

AB - The systemic absorption of ocularly applied tritiated [D‐Ala2]metenkephalinamide (YAGFM) and inulin was studied in the albino rabbit with respect to rate, extent, pathways, and vehicle effects and compared with epinephrine. Peak concentration was achieved within 20 min except for inulin, for which absorption was still ongoing at 120 min. For YAGFM, the apparent absorption rate was slower than the elimination rate, thus obeying “flip‐flop” pharmacokinetics. Based on the area under the plasma concentration curve from zero to 120 min, the percent of dose systemically absorbed was 36.1 ± 4.4% for YAGFM, at least 3.3 ± 0.2% for inulin, and 58.5 ± 4.4% for epinephrine. This suggests that loss of drug to the systemic circulation is a more important factor in reducing the ocular absorption of YAGFM than for inulin. The conjunctival mucosa played as important a role as the nasal mucosa in the systemic absorption of YAGFM, while playing a secondary role in the case of inulin. Unlike nonpeptide drugs, the systemic absorption of ocularly administered YAGFM and inulin was not adversely affected by incorporation in 5% polyvinyl alcohol. Overall, the contact time of the instilled dose with the conjunctival and the nasal mucosae, their intrinsic permeability, and the extent of dilution of the instilled dose are key factors determining the vehicle effects on the extent of systemic absorption of ocularly applied peptides.

UR - http://www.scopus.com/inward/record.url?scp=0024208342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024208342&partnerID=8YFLogxK

U2 - 10.1002/jps.2600771005

DO - 10.1002/jps.2600771005

M3 - Article

VL - 77

SP - 838

EP - 842

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 10

ER -